About
Glycan targeted carbohydrate binding modules
Areas of Focus
Categories
Biologics & Biopharmaceutical
Team (24)
Associate Professor Sanjay Haresh Chotirmall
Associate Professor Sanjay Haresh ChotirmallCurrent professional and academic roles include Associate Professor and Provost’s Chair of Molecular Medicine at the Lee Kong Chian School of Medicine,...
Pneumagen
team_memberboard_chair
Charles Haworth
Dr Charles HaworthConsultant Respiratory Physician, Cambridge Centre for Lung Infection at Royal Papworth Hospital England, he specialises in treating adults with cystic fibrosis, bronchiectasis and...
Pneumagen
team_member
Douglas Thomson
Douglas ThomsonChief Executive OfficerDouglas Thomson is Chief Executive Officer and co-founder at Pneumagen. His background is in infectious disease vaccine research and development. He was...
Pneumagen
team_memberexecutivefounder
Dr Charles Haworth
Dr Charles HaworthConsultant Respiratory Physician, Cambridge Centre for Lung Infection at Royal Papworth Hospital England, he specialises in treating adults with cystic fibrosis, bronchiectasis and...
Pneumagen
team_member
Dr John Beadle
Dr John BeadleNon-executive DirectorJohn Beadle is a Non-Executive Director at Pneumagen. During his career, John has formed and led several innovative advanced therapy biotech companies through...
Pneumagen
team_memberboard_chairexecutive
Dr Richard Webby
Dr Richard WebbyDr Richard Webby is a Member of the Department of Infectious diseases at St Jude Children’s Research Hospital and Director of the World Health Organization Collaborating Centre for...
Pneumagen
team_member
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
164
By Phase
PHASE2: 1PHASE1: 1
By Status
COMPLETED: 2
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
Today
Hover over trial bars to see details
Recent Trials
NCT05507567Lead Sponsor
Safety, Tolerability and Prophylactic Antiviral Activity of Neumifil Against Influenza Via a Human Viral Challenge Model
PHASE2Completed
104 participants
Started: Aug 12, 2022 · Completed: May 4, 2023
NCT05093530Lead Sponsor
Safety and Tolerability of Single and Multiple Doses of Neumifil
PHASE1Completed
60 participants
Started: Oct 12, 2021 · Completed: Apr 5, 2022
Locations (1)
Headquarters
St. Andrews, UK
Map
Loading map...